MIV Therapeutics, Inc. (OTCBB:MIVT - News; FWB:MIV), a leading developer of new generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, announced today that it has entered a collaborative agreement with Sahajanand Medical Technologies, a manufacturer of stents and drug-eluting stents.
